Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.56 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7695964 | 1.00 | SLC18A2 (0.56) | SLC18A2SIGMAR1OPRM1OPRD1OPRK1 | |
| SCHEMBL5556346 | 0.83 | GAA (0.59) | SIGMAR1GAAHRH3 | |
| SCHEMBL5375336 | 0.83 | GAA (0.59) | SIGMAR1GAAHRH3 | |
| SCHEMBL7693290 | 0.82 | OPRM1 (0.50) | SIGMAR1OPRM1OPRD1OPRK1 | |
| SCHEMBL7694810 | 0.82 | SIGMAR1 (0.52) | SIGMAR1OPRM1OPRD1OPRK1GAA | |
| SCHEMBL7689651 | 0.76 | SIGMAR1 (0.41) | SIGMAR1OPRM1OPRD1OPRK1GAA | |
| SCHEMBL4819317 | 0.76 | SLC18A2 (0.69) | SLC18A2 | |
| SCHEMBL7691973 | 0.74 | GAA (0.47) | SLC18A2SIGMAR1OPRM1OPRD1OPRK1 | |
| SCHEMBL5557549 | 0.73 | SIGMAR1 (0.68) | SIGMAR1 | |
| SCHEMBL5557553 | 0.73 | SIGMAR1 (0.68) | SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002012184-A1 | PROCESS FOR PREPARING ALPHA-AMINO ACIDS AND THEIR DERIVATIVES INCLUDING PHENYLALANINE AND HOMOPHENYLALANINE AND THEIR INTERMEDIATES | CHEMBIONEX CO., LTD. (KR) | 2002-02-14 | — | — | WO | disclosed |